Analysts think ASND stock price could increase by 66%
Feb 12, 2025, 12:25 PM
27.50%
What does ASND do
Ascendis Pharma A/S is a global biopharmaceutical company developing drug candidates for growth hormone deficiency, endocrinology, CNS disorders, infectious diseases, and diabetes. It operates through multiple subsidiaries in Germany and Denmark.
18 analysts think ASND stock price will increase by 66.43%. The current median analyst target is $198.90 compared to a current stock price of $119.51. The lowest analysts target is $154.53 and the highest analyst target is $303.45.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
